A novel GATA4 mutation leading to congenital ventricular septal defect

Chinese Journal of Medical Genetics

Volumn 27, Issue 5, 2010, Pages 512-516

  Yang, Yi Qing ^a   Tang, Yong Qing ^b   Liu, Xing Yuan ^b   Lin, Xiao Ping ^b   Chen, Yi Han ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Congenital heart disease; GATA4 gene transcriptional factor; Mutation

Indexed keywords

AMINO ACID; ATRIAL NATRIURETIC FACTOR; DIDEOXYNUCLEOTIDE; ENHANCED GREEN FLUORESCENT PROTEIN; GLUTAMIC ACID; GLYCINE; LIPOFECTAMINE; PLASMID VECTOR; TRANSCRIPTION FACTOR GATA 4;

ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONGENITAL HEART MALFORMATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXON; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HEART VENTRICLE SEPTUM DEFECT; HELA CELL; HUMAN; INTRON; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MOLECULAR CLONING; MUTAGENESIS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; EXONS; FEMALE; GATA4 TRANSCRIPTION FACTOR; HEART SEPTAL DEFECTS, VENTRICULAR; HELA CELLS; HUMANS; INFANT; MALE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; SEQUENCE ALIGNMENT;

EID: 78049281914     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-9406.2010.05.008     Document Type: Article

References (13)

1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol,2002,39:1890-1900.
2. Rosamond W, Flegal K, Furie K, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation,2008,117: e25-e146.
3. Diab KA, Cao QL, Hijazi ZM. Device closure of congenital ventricular septal defects. Congenit Heart Dis,2007,2:92-103.
4. Szili-Torok T, Kornyei L, Jordaens LJ. Transcatheter ablation of arrhythmias associated with congenital heart disease. J Interv Card Electrophysiol,2008,22:161-166.
5. Bisping E, Ikeda S, Kong SW, et al. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc Natl Acad Sci U S A,2006,103:14471-14476.
6. Oka T, Maillet M, Watt AJ, et al. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res,2006,98:837-845.
7. Garg V, Kathiriya IS, Barnes R, et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature,2003,424:443-447.
8. Weismann CG, Gelb BD. The genetics of congenital heart disease: a review of recent developments. Curr Opin Cardiol,2007,22:200-206.
9. Matsuoka R. GATA4 mutation and congenital cardiovascular diseases, importance of phenotype and genetic background clarification. J Mol Cell Cardiol,2007,43:667-669.
10. Pikkarainen S, Tokola H, Kerkela R, et al. GATA transcription factors in the developing and adult heart. Cardiovasc Res,2004,63:196-207. (Pubitemid 38900834)
11. Heikinheimo M, Scandrett JM, Wilson DB. Localization of transcription factor GATA4 to regions of the mouse embryo involved in cardiac development. Dev Biol,1994,164:361-373.
12. Kuo CT, Morrisey EE, Anandappa R, et al. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev,1997,11:1048-1060.
13. Molkentin JD, Lin Q, Duncan SA, et al. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev,1997,11:1061-1072.